These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 8344685)

  • 1. [Follow-up study of the development of autoantibodies in patients with chronic inflammatory bowel disease under anti-CD4 therapy].
    Buchwald S; Emmrich J; Seyfarth M; Emmrich F
    Immun Infekt; 1993 Apr; 21 Suppl 1():34-5. PubMed ID: 8344685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibody therapy of inflammatory bowel disease.
    van Deventer SJ; Camoglio L
    Aliment Pharmacol Ther; 1996; 10 Suppl 2():107-11; discussion 112. PubMed ID: 8899109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of ulcerative colitis and Crohn's disease with monoclonal antibody].
    Asakura H
    Nihon Rinsho; 2002 Mar; 60(3):531-8. PubMed ID: 11904969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5.
    Fuss IJ; Neurath M; Boirivant M; Klein JS; de la Motte C; Strong SA; Fiocchi C; Strober W
    J Immunol; 1996 Aug; 157(3):1261-70. PubMed ID: 8757634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antineutrophil cytoplasmic autoantibodies in inflammatory bowel diseases.
    Colombel JF; Reumaux D; Duthilleul P; Noël LH; Gower-Rousseau C; Paris JC; Cortot A
    Gastroenterol Clin Biol; 1992; 16(8-9):656-60. PubMed ID: 1426820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunosuppressive agents in the treatment of Crohn's disease and ulcerative colitis.
    Hibi T; Iwao Y; Yajima T; Inoue N; Ueno Y; Takaishi H; Watanabe M; Ishii H
    J Gastroenterol; 1995 Nov; 30 Suppl 8():121-3. PubMed ID: 8563872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal antibody therapy of inflammatory bowel disease.
    van Deventer SJ; Camoglio L
    Pharm World Sci; 1997 Apr; 19(2):55-9. PubMed ID: 9151342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positioning novel biologic, probiotic, and apheresis therapies for Crohn's disease and ulcerative colitis.
    Egan LJ; Sandborn WJ
    Curr Gastroenterol Rep; 2005 Dec; 7(6):485-91. PubMed ID: 16313879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Autoantibodies against the exocrine pancreas and against intestinal goblet cells in the diagnosis of Crohn's disease and ulcerative colitis].
    Stöcker W; Otte M; Ulrich S; Normann D; Stöcker K; Jantschek G
    Dtsch Med Wochenschr; 1984 Dec; 109(51-52):1963-9. PubMed ID: 6150841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Activation of T-lymphocytes in Crohn disease and in ulcerative hemorrhagic rectocolitis. Therapeutic implications].
    Voiglio E; Salle B; Lemaitre D; Cloix P; Bancel B; Cozon G
    Pathol Biol (Paris); 1996 Apr; 44(4):287-92. PubMed ID: 8763593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapy of chronic inflammatory intestinal disease].
    Van Gossum A
    Rev Med Brux; 2000 Dec; 21(6):A513-5. PubMed ID: 11194501
    [No Abstract]   [Full Text] [Related]  

  • 12. [Follow-up of chronic inflammatory bowel disease. A 10-year material].
    Jacobsen CD; Skjøtø J; Pytte R; Lygren I
    Tidsskr Nor Laegeforen; 1994 Feb; 114(6):674-7. PubMed ID: 8191448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Granulocyteaphaeresis in steroid-dependent inflammatory bowel disease: a prospective, open, pilot study.
    Domènech E; Hinojosa J; Esteve-Comas M; Gomollón F; Herrera JM; Bastida G; Obrador A; Ruiz R; Saro C; Gassull MA;
    Aliment Pharmacol Ther; 2004 Dec; 20(11-12):1347-52. PubMed ID: 15606397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Anti-TNF antibodies in the treatment of intestinal inflammatory disease].
    Hinojosa J
    Gastroenterol Hepatol; 2000 May; 23(5):250-7. PubMed ID: 10902280
    [No Abstract]   [Full Text] [Related]  

  • 15. Interferon alpha (IFN alpha 2a) therapy for herpes virus-associated inflammatory bowel disease (ulcerative colitis and Crohn's disease).
    Ruther U; Nunnensiek C; Muller HA; Bader H; May U; Jipp P
    Hepatogastroenterology; 1998; 45(21):691-9. PubMed ID: 9684118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review article: a critical approach to new forms of treatment of Crohn's disease and ulcerative colitis.
    Seegers D; Bouma G; Peña AS
    Aliment Pharmacol Ther; 2002 Jul; 16 Suppl 4():53-8. PubMed ID: 12047261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of inflammatory bowel disease in France: a nationwide survey among private gastroenterologists.
    Duchesne C; Faure P; Kohler F; Pingannaud MP; Bonnaud G; Devulder F; Abramowitz L; Boustière C; Peyrin-Biroulet L;
    Dig Liver Dis; 2014 Aug; 46(8):675-81. PubMed ID: 24809234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
    Nørgård BM
    Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytapheresis in inflammatory bowel diseases: current evidence and perspectives.
    Danese S; Angelucci E; Stefanelli T; Omodei P; Luigiano C; Finazzi S; Pagano N; Repici A; Vecchi M; Malesci A
    Digestion; 2008; 77(2):96-107. PubMed ID: 18382085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new type of perinuclear anti-neutrophil cytoplasmic antibody (p-ANCA) in active ulcerative colitis but not in Crohn's disease.
    Rump JA; Schölmerich J; Gross V; Roth M; Helfesrieder R; Rautmann A; Lüdemann J; Gross WL; Peter HH
    Immunobiology; 1990 Nov; 181(4-5):406-13. PubMed ID: 2099908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.